Neobiological frontier: What innovations are in store in 2022?

Credit: istock.com/Magnilion
Credit: istock.com/Magnilion

We turned to some of the visionaries and innovators who normally help us see deeply into the future and asked them to make some predictions about the next 11 months.

Our question was simple: What is the most exciting, impactful, or scary development you’re anticipating in 2022 in your field? 

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Harvard professor David Sinclair anticipates, “Tens of billions of dollars will be invested in longevity research in a race to find molecules that reverse age.”

And he predicts that in 2022, “the first drug to slow aging will enter the final stage of human clinical trials,” which he said could be an NAD booster (which is in phase 2) or metformin or a senolytic. 

[W]e asked our friend Amir Kalali, a pioneer of drug development and life sciences innovation and founder and chairman of the CNS Summit, what he sees as he scans the horizon.

His first prediction is that “non-molecular approaches to treating brain disorders will be taken seriously based on robust data.” Included among those approaches are neuromodulation utilizing electrical impulses as the currency of the brain, light, or sound.

It will also include the innovative use of video games and XR (including virtual, augmented, and mixed reality) to treat neuropsychiatric illnesses and many other things.

This is an excerpt. Read the original post here. 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.